Antheia’s 2022 in Review: A Year of Value

This year has been ripe with growth, major achievements, and opportunities to showcase who and what make Antheia the visionary business it is. Nearly eight years ago, we co-founded Antheia…
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing

Upstream bioprocessing – better known in biomanufacturing as fermentation – is directly followed by downstream bioprocessing (DSP). Just as fermentation is all about maximizing the production of a target compound, DSP focuses
Syn Bio Companies Put the Earth into Focus

While some synthetic biology companies are using biology to improve our food, clothes, and medicine, others are turning their attention to helping the Earth.
On Heels of $17 Billion SPAC Deal, Ginkgo Inks Collab with Synthetic Biology Firm

California synthetic biology firm Antheia has joined forces with Boston-based biotech company Ginkgo Bioworks to strengthen its efforts to develop and produce essential medicines to treat a wide range of diseases…
Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology

Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to accelerate the development…
Out to revamp plant-based drug manufacturing, Antheia locks in partnership with synthetic biology…

With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy, synthetic biology upstart Antheia…
Female-Founded Antheia Raises $73 Million to Support Synthetic Biology for Essential Medicines

Synthetic biology startup Antheia raised $73 million in Series B financing to support the company’s efforts to bring its first plant-based medicine to market and support the production of necessary…
Investing in the next wave of biomanufacturing technologies for pharma

The global pandemic has brought pharmaceutical manufacturing to the forefront of America’s public consciousness. Acute drug shortages brought on by COVID-19 have underscored the need for domestic production and more resilient supply chains…
Meet the Team – Our Lab Operations Team

For the final installation in our “Meet the Team” series, we hear from Olivia, Khurram and Vicky, who lead our operations. This team is the key to ensuring Antheia’s labs are running successfully and efficiently…
Scaling synthetic biology as a manufacturing platform

For decades, synthetic biology has promised to make manufacturing more efficient, sustainable, and responsive to sudden changes in supply and demand. It has the potential to create new value across industries by transforming everything from food to pharmaceuticals…